Accelerating Treatments for Cancer

 Our CovAI™ Platform: Integrating the latest advances in Machine Learning, Artificial Intelligence, structural biology, and physics-based simulations to model the full spectrum of protein dynamics and design first-in-class and best-in-class covalent drugs for cancer.

Our team of experts works tirelessly to discover new and innovative drugs that target a variety of diseases. We use state-of-the-art technology and cutting-edge research techniques to develop drugs that have the potential to change lives.

Our bioinformatics team works on analyzing and interpreting large amounts of biological data. We use advanced algorithms and machine learning techniques to gain insights into complex biological systems.